Package 80425-0373-3

{"route": ["ORAL"], "spl_id": "10a898a2-543a-9e04-e063-6294a90a7731", "openfda": {"nui": ["N0000008486", "N0000185506", "N0000182140"], "unii": ["0H73WJJ391"], "rxcui": ["199889"], "spl_set_id": ["10a9e6fa-4d55-6b5c-e063-6294a90a608c"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_moa": ["Cytochrome P450 3A4 Inducers [MoA]", "Cytochrome P450 2C19 Inhibitors [MoA]"], "manufacturer_name": ["Advanced Rx Pharmacy of Tennessee, LLC"]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET in 1 BOTTLE (80425-0373-1)", "package_ndc": "80425-0373-1", "marketing_start_date": "20240205"}, {"sample": false, "description": "60 TABLET in 1 BOTTLE (80425-0373-2)", "package_ndc": "80425-0373-2", "marketing_start_date": "20240205"}, {"sample": false, "description": "90 TABLET in 1 BOTTLE (80425-0373-3)", "package_ndc": "80425-0373-3", "marketing_start_date": "20240205"}], "brand_name": "Topiramate", "product_id": "80425-0373_10a898a2-543a-9e04-e063-6294a90a7731", "dosage_form": "TABLET", "pharm_class": ["Cytochrome P450 2C19 Inhibitors [MoA]", "Cytochrome P450 3A4 Inducers [MoA]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "80425-0373", "generic_name": "Topiramate", "labeler_name": "Advanced Rx Pharmacy of Tennessee, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Topiramate", "active_ingredients": [{"name": "TOPIRAMATE", "strength": "100 mg/1"}], "application_number": "ANDA076343", "marketing_category": "ANDA", "marketing_start_date": "20240205", "listing_expiration_date": "20261231"}